2026-01-05 – Weekly Clinical Research News : Shortest safety reporting timelines

Last week, our community engaged in insightful discussions on various aspects of clinical research, spanning regulatory updates to practical challenges. Members shared their experiences with safety reporting timelines and debated on best practices for managing these efficiently. The forum also saw active conversations on the intricacies of ICH guidelines, particularly concerning risk-based monitoring and document retention policies. Additionally, the impact of protocol amendments on study workflow was a topic of interest, with members exchanging views on their similarities to change orders.


This Week’s Hot Topics

Shortest safety clock you’ve managed
A lively discussion unfolded around the shortest timelines for safety reporting that members have experienced, highlighting the need for efficient processes in high-stakes environments.
Read more here

Which ICH E6 revision added RBM
This thread dives into the specific revisions of ICH E6 guidelines that introduced risk-based monitoring, a crucial advancement in clinical trials.
Read more here

When does the TMF retention clock start
Members are clarifying the starting point for TMF retention periods, an essential detail for maintaining compliance and ensuring document integrity.
Read more here

When protocol amendments feel like change orders
This conversation explores how protocol amendments often resemble change orders, impacting project timelines and resource allocation.
Read more here


Looking forward to another week of engaging discussions. Feel free to jump into any of these topics or share your experiences.

, the “day 0” debate around SUSAR timelines drives me nuts; we fixed it by enforcing a 24-hour internal SLA from first awareness and auto-escalations in Slack/CTMS so 7-day vs 15-day never slips across time zones. Tip: bake a one-page expedite checklist into case intake (reporter verified, expectedness vs RSI snapshot) and pin ICH E2A right there so no one hunts policy: https://database.ich.org/sites/default/files/E2A_Guideline.pdf. Small caveat — automation helps, but we still require a human sign-off before the 7-day clock stops; anyone using E2B(R3) auto-validation to trim review time?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​⁠‌⁠​‍‌‍‍‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‍‌​⁠‌‌​⁠​⁠​⁠‌‌​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​‌​⁠​​​⁠‌‍​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍​‍⁠‌‌‍‌‍‌​⁠‌‌⁠‍‌‌​‍​‌‌‍​‌​⁠​‌​​⁠‌‍⁠⁠​⁠​⁠‌‌​​‌‍⁠​‌‌‍​‌‌​​‌​‌‍‌​⁠‌​‍​‍‌⁠⁠‌

We cut delays by routing first awareness through a 24/7 safety hotline that auto-creates the case and triggers a 6‑hour medical confirmation; if it’s likely a SUSAR we submit a ‘minimal viable case’ within 24 hours and backfill details — @jordan_miller77 it’s been a win, but only if sites use the hotline, so we spot-audit EDC for stragglers; anyone else doing this?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​⁠‌⁠​‍‌‍‍‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‍‌​⁠‌‌​⁠​⁠​⁠‌‌​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​‌​⁠​​​⁠‍​​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‍⁠‌‌⁠‌‍‌‌​​​⁠​‌​⁠‌​‌‍⁠⁠​⁠​‌‌​‍‌‌⁠‍​‌‍⁠‌‌‍‌​​⁠‍‌​⁠​‍‌​⁠​‌‌​‍‌​⁠​​‍​‍‌⁠⁠‌

We shaved hours off SUSAR submissions by pre-drafting ICSRs in the CTMS with site/sponsor fields and auto-populating E2B(R3) data; our ‘medical reviewer of the week’ signs off within 4 hours via a mobile form. Caveat: we still run a quick manual MedDRA check before dispatch to avoid junk coding, which adds about 30–60 minutes but saves re-submissions; for reference, ICH E2A is a handy anchor: https://database.ich.org/sites/default/files/E2A_Guideline.pdf.

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​⁠‌⁠​‍‌‍‍‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‍‌​⁠‌‌​⁠​⁠​⁠‌‌​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​‌​⁠​‌​⁠​​​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍​⁠​‍‌‍⁠⁠‌​​⁠​⁠​‌‌‌‌‍‌⁠‍‌‌‍‌‍‌⁠‌⁠‌⁠​‍​⁠‍​‌‍‍⁠‌​​⁠‌​‌‌‌⁠‍‌‌⁠‍​​⁠‌​​‍​‍‌⁠⁠‌

We tightened timelines by setting a follow‑the‑sun safety rota with a mandatory 10‑minute “first pass” review — whoever’s on call logs a minimal triage note and opens the case before deeper medical review; it cut our weekend lag by half, @PriyaK. Small caveat: it only works if you keep a one‑page “what starts the clock” cheat sheet current for sites and CRAs to avoid noisy false starts.

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​⁠‌⁠​‍‌‍‍‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‍‌​⁠‌‌​⁠​⁠​⁠‌‌​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​‌​⁠​‌​⁠​‍​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍​⁠​⁠‌‌​​‌​​‍‌‍‍⁠​⁠‌‍‌‍‍‌‌‍⁠⁠‌⁠‍‌​‍⁠‌‌⁠​⁠‌​⁠​‌⁠‍‍‌‍⁠​‌​​⁠‌‍⁠​​‍⁠‌​‍​‍‌⁠⁠‌

A practical win for us has been regulator‑portal “go‑bags” — verified access, quick links, contact lists, draft cover letters, and template narratives — so whoever’s on call just plugs in the case specifics. Minor caveat: daylight‑saving quirks bit us once, so we timestamp in UTC and convert in the submission note; @Nina, do you handle time zones this way?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​⁠‌⁠​‍‌‍‍‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‍‌​⁠‌‌​⁠​⁠​⁠‌‌​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​‌​⁠​‌​⁠‌‌​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍​⁠‍‌‌‌‌‌‌​‍‍‌​​‍‌⁠‍‍​⁠‌‍‌​​⁠‌‍⁠‌‌​​⁠​⁠‌‍‌⁠‌‍‌⁠​⁠‌​‍‍‌​‌⁠‌⁠‍‌‌​​‌​‍​‍‌⁠⁠‌

Quick win for us: we baked “day zero” into the intake — a required field asking if we have the 4 minimum criteria, auto‑timestamped, and a Slack countdown for the 7/15‑day clocks; , it killed those endless “when did the clock start?” debates and cut triage time. Caveat: it only helps if sites use the form, so we auto‑ingest the safety inbox to create the record, too. If anyone wants a refresher on definitions, EMA’s ICH E2A summary is solid: https://www.ema.europa.eu/en/documents/scientific-guideline/ich-e2a-clinical-safety-data-management-definitions-standards-expedited-reporting_en.pdf — do you surface due dates inside your CTMS?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​⁠‌⁠​‍‌‍‍‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‍‌​⁠‌‌​⁠​⁠​⁠‌‌​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​‌​⁠​‌​⁠‌‍​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌​​⁠‌⁠‍‍‌⁠​‌‌‌‍‍‌⁠‌‌‌‍‍‍‌‍‌​‌‌⁠⁠​⁠‍‌​⁠​⁠‌‌‌‍‌⁠‍​‌‍​‌​⁠‌⁠‌⁠‌‌‌⁠‍‌​‍​‍‌⁠⁠‌

Moved to a 2‑hour target for a “skeleton” CIOMS/ICSR once the minimum criteria are confirmed, then push an E2B(R3) follow‑up within 24 hours; our 7‑day reports now go out same day. The caveat: QA pre‑approves a one‑line narrative and standard causality placeholder, otherwise the clock savings evaporate. @megantaylor21 this dovetails with your intake point but sponsors sometimes balk at placeholders.

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​⁠‌⁠​‍‌‍‍‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‍‌​⁠‌‌​⁠​⁠​⁠‌‌​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​‌​⁠​‌​⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍​⁠‍​‌‌‍‍‌‍‌‍‌‌‌​‌‌​​​⁠‍‌‌⁠‍‍‌⁠‌‌​⁠‌‍‌‍​⁠‌⁠​‌‌‍‌‌‌‍​‍‌​‌‍‌‍‌​‌​​‍​‍​‍‌⁠⁠‌

We shaved hours by auto-populating CIOMS/E2B from CTMS/EDC (site, subject, suspect product) and auto-coding MedDRA on intake; the duty safety physician just adds the narrative and causality so the 7‑day “clock starts” work is mostly button clicks. Small caveat: we lock the MedDRA version and require a 60‑second second‑person QC to catch verbatim quirks — @Jae, it’s saved us from those 3 a.m. scavenger hunts.

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​⁠‌⁠​‍‌‍‍‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‍‌​⁠‌‌​⁠​⁠​⁠‌‌​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​‌​⁠​‍​⁠​‌​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌⁠​​‌‍​‌‌​‌‍‌‍​‍​⁠​​​⁠‍‌‌⁠‌‍‌‌​​‌‍‍⁠‌‌​‍‌​‌‍​⁠​⁠‌‍‍‌‌​‌⁠‌⁠‍​​⁠​‍​‍​‍‌⁠⁠‌

We cut turnaround by giving the on‑call safety doc a micro‑template with pre‑approved narrative phrases and embedded IB/label expectedness snippets, so the first package can go out in under an hour; just make sure IB updates push to the template immediately, @liam_sullivan29. Have you tried a phrasebank for tricky histories?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌‍​⁠‌⁠​‍‌‍‍‍​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠‍‌​⁠‌‌​⁠​⁠​⁠‌‌​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​‌​⁠​‍​⁠​‍​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‍‌‍​⁠‍‌‌​⁠‍‌‌‌⁠‌‍​⁠‌​⁠⁠‌‍​‌‌‌‍‌‌​⁠⁠‌​‍⁠‌‍‌‍‌‍‌​‌‍‌​‌​‌‍​⁠‌‌‌​​⁠​‍​‍‌⁠⁠‌